Finance

Lists
4DX:ASX
4DMedical Ltd
2,19 A$
0,00%
(0,00) 1D
16 նոյ, 16:20:41 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for 4DX...
Mkt. cap
1,32 մլրդ
Avg. vol.
5,12 մլն
Volume
0,00
52-wk high
7,55 A$
52-wk low
1,40 A$
EPS
-0,38 A$
Shares outstanding
602,34 մլն
No. of employees
181
Mkt. cap
1,32 մլրդ
Avg. vol.
5,12 մլն
Volume
0,00
52-wk high
7,55 A$
52-wk low
1,40 A$
EPS
-0,38 A$
Shares outstanding
602,34 մլն
No. of employees
181
News stories
From web sources and news partners
Profile
4DMedical is a medical technology company, based in Australia and the United States. 4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report. 4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
About 4DMedical Ltd
CEOAndreas Fouras
Employees181
Founded2013
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,43 մլն
1,43 մլն
2,10 մլն
2,10 մլն
Cost of goods sold
98,18 հզր
98,18 հզր
121,86 հզր
121,86 հզր
Cost of revenue
98,18 հզր
98,18 հզր
121,86 հզր
121,86 հզր
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,22 մլն
9,22 մլն
10,40 մլն
10,40 մլն
Operating expense
14,59 մլն
14,59 մլն
17,45 մլն
17,45 մլն
Total operating expenses
14,68 մլն
14,68 մլն
17,58 մլն
17,58 մլն
Operating income
-13,26 մլն
-13,26 մլն
-15,47 մլն
-15,47 մլն
Other non operating income
5,12 մլն
5,12 մլն
2,42 մլն
2,42 մլն
EBT including unusual items
-77,54 մլն
-77,54 մլն
-25,25 մլն
-25,25 մլն
EBT excluding unusual items
-77,54 մլն
-77,54 մլն
-25,22 մլն
-25,22 մլն
Income tax expense
-466,23 հզր
-466,23 հզր
-100,48 հզր
-100,48 հզր
Effective tax rate
0,60%
0,60%
0,40%
0,40%
Other operating expenses
4,00 մլն
4,00 մլն
5,69 մլն
5,69 մլն
Net income
-77,07 մլն
-77,07 մլն
-25,15 մլն
-25,15 մլն
Net profit margin
-5 404,23%
-5 404,23%
-1 194,85%
-1 194,85%
Earnings per share
-
-
-
-
Interest and investment income
91,67 հզր
91,67 հզր
2,15 մլն
2,15 մլն
Interest expense
-69,49 մլն
-69,49 մլն
-14,18 մլն
-14,18 մլն
Net interest expenses
-69,40 մլն
-69,40 մլն
-12,03 մլն
-12,03 մլն
Depreciation and amortization charges
1,37 մլն
1,37 մլն
1,36 մլն
1,36 մլն
EBITDA
-12,66 մլն
-12,66 մլն
-15,35 մլն
-15,35 մլն
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps